[New technology of diagnosis of ovarian cancer].
It is difficult to identify early ovarian cancer at present. However, some tumor markers (CA125, CA19-9, CEA) and soon imaging system (MRI, CT, UT) and some oncogenes are available for diagnosis of ovarian cancer recently. Multivariate analysis of tumor markers has a possibility of stage I cancer. MRI is very useful to identify some cystic and hemorrhagic lesions. Amplifiers of N-myc and K-ras may be applied to diagnose ovarian cancer. In future, these new technologies may identify early ovarian cancer.
Terashima
Y
Y
Dept. of Obstetrics and Gynecology, Jikei University School of Medicine.
D000230:Adenocarcinoma / Q000175:diagnosis / Q000235:genetics; D002288:Adenocarcinoma, Mucinous / Q000175:diagnosis / Q000235:genetics; D000328:Adult; D000368:Aged; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D003536:Cystadenocarcinoma / Q000175:diagnosis / Q000235:genetics; D005260:Female; D005784:Gene Amplification; D011905:Genes, ras; D006801:Humans; D008875:Middle Aged; D009857:Oncogenes; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor